Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis

Sherie Smith; Rebecca Calthorpe; Sophie Herbert; Alan R. Smyth

doi:10.1002/14651858.CD013733

Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis

Sherie Smith^*, Rebecca Calthorpe, Sophie Herbert, Alan R. Smyth

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

38 Downloads (Pure)

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects of using digital technology to monitor adherence to inhaled therapies and health status in pwCF.

Original language	English
Article number	CD013733
Number of pages	14
Journal	Cochrane Database of Systematic Reviews
Volume	2020
Issue number	9
DOIs	https://doi.org/10.1002/14651858.CD013733
Publication status	Published - 16 Sept 2020
Externally published	Yes

Bibliographical note

Funding Information:
This project was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to the Cochrane Cystic Fibrosis and Genetic Disorders Group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health.

Publisher Copyright:
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

ASJC Scopus subject areas

Pharmacology (medical)

Access to Document

10.1002/14651858.CD013733Licence: Unspecified

Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. This work is made available online in accordance with the publisher’s policies. Please refer to any applicable terms of use of the publisher.
Final published version, 173 KBLicence: Unspecified

Cite this

@article{c427fdd451464d74a4cda24f7a86c994,

title = "Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis",

abstract = "Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects of using digital technology to monitor adherence to inhaled therapies and health status in pwCF.",

author = "Sherie Smith and Rebecca Calthorpe and Sophie Herbert and Smyth, {Alan R.}",

note = "Funding Information: This project was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to the Cochrane Cystic Fibrosis and Genetic Disorders Group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health. Publisher Copyright: Copyright {\textcopyright} 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.",

year = "2020",

month = sep,

day = "16",

doi = "10.1002/14651858.CD013733",

language = "English",

volume = "2020",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "Wiley-Blackwell",

number = "9",

}

TY - JOUR

T1 - Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis

AU - Smith, Sherie

AU - Calthorpe, Rebecca

AU - Herbert, Sophie

AU - Smyth, Alan R.

N1 - Funding Information: This project was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to the Cochrane Cystic Fibrosis and Genetic Disorders Group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health. Publisher Copyright: Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

PY - 2020/9/16

Y1 - 2020/9/16

N2 - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects of using digital technology to monitor adherence to inhaled therapies and health status in pwCF.

AB - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects of using digital technology to monitor adherence to inhaled therapies and health status in pwCF.

U2 - 10.1002/14651858.CD013733

DO - 10.1002/14651858.CD013733

M3 - Article

AN - SCOPUS:85091035408

SN - 1465-1858

VL - 2020

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 9

M1 - CD013733

ER -

Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis

Abstract

Bibliographical note

ASJC Scopus subject areas

Access to Document

Fingerprint

Cite this